Reparixin, a CXCR1/2 inhibitor in islet allotransplantation. - Wikidata - wikimedia - TriplyDB

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

http://www.wikidata.org/entity/Q37268202

about

Redox-Dependent Inflammation in Islet Transplantation Rejection.

P2860

Q54944633-387F768B-A3C1-4B82-80CC-80D4E1230BCF

P2860

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

http://www.wikidata.org/entity/Q37268202

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

@en

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

@nl

type

label

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

@en

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

@nl

prefLabel

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

@en

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

@nl

P1433

Q37268202-C0FD8786-9D40-4A3D-BA52-92694B661676

P1476

Q37268202-4DCE531E-CBB9-4689-9471-BCC463D229DF

P2093

Q37268202-316CC9C1-6BDA-4041-A9E5-FD4C278BC9A1

Q37268202-47B22419-4E7A-42CB-9FAB-362879259B87

Q37268202-6112355F-1829-4BBC-B2FB-204E81591A83

Q37268202-8041ABDE-C1B7-4314-BB59-642FDA8C4596

Q37268202-81EE0996-8766-4442-9D0D-6A7DAEA55769

Q37268202-9A61255C-338C-439B-8AE2-C56BA785ED6F

Q37268202-D0CB32D9-0BDE-4987-86E5-D7133B6DFABD

Q37268202-D8632A58-27CE-4A02-B3CA-1A67AC3935E9

Q37268202-EFF36362-6DB4-4B24-A26B-03863FB8DE17

P2860

Q37268202-022E418E-1894-43CC-A541-7B14066399B9

Q37268202-0EE6E3FB-3715-4CE7-9871-B9AF846E83EA

Q37268202-2BDA9015-7B28-4C12-9026-28C7D00FC434

Q37268202-2C6D9046-FA79-4672-B7F7-027C3B8AA08C

Q37268202-306FF0C3-B516-4001-A819-7D7AA6A66441

Q37268202-322E1B46-193C-4E18-84FC-017AADE876ED

Q37268202-36916A50-5E0E-431B-891A-E8CE116EC655

Q37268202-631EFFC9-B72C-4110-B6DA-77E481803BC3

Q37268202-6F06B886-11A6-4164-8D50-7E42D7DE60ED

Q37268202-732716A6-D8AF-43B2-AE52-EE77F8077461

P304

Q37268202-48A4C1C4-89A0-4B98-A62A-C55A0B285247

P31

Q37268202-F3C3F7C1-6E30-40ED-A601-C887A531DF4D

P356

Q37268202-5A027066-52DF-436E-B825-2F7341084668

P433

Q37268202-5C8ECE3B-1888-4BCC-A770-DD2357D61817

P478

Q37268202-93F28B41-072F-4DAF-BDE0-8CA64C95F0D5

P577

Q37268202-BCDE0D04-1EE7-4D21-833A-B643DA28428E

P698

Q37268202-AA547DC6-476E-49A2-9C6E-88FAF9AF78A2

P932

Q37268202-8B02AC7B-26BB-439E-839F-796C11B3335A

P356

19382014.2016.1199303

P1433

P1476

Reparixin, a CXCR1/2 inhibitor in islet allotransplantation.

@en

P2093

A M James Shapiro

http://www.w3.org/2001/XMLSchema#string

Andrew R Pepper

http://www.w3.org/2001/XMLSchema#string

Antonio Bruni

http://www.w3.org/2001/XMLSchema#string

Boris Gala-Lopez

http://www.w3.org/2001/XMLSchema#string

John Wink

http://www.w3.org/2001/XMLSchema#string

Mariusz Bral

http://www.w3.org/2001/XMLSchema#string

Nasser Abualhassen

http://www.w3.org/2001/XMLSchema#string

Rena L Pawlick

http://www.w3.org/2001/XMLSchema#string

Yasmin Rafiei

http://www.w3.org/2001/XMLSchema#string

P2860

Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2

Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis.

Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats.

Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.

CXCR1/2 inhibition enhances pancreatic islet survival after transplantation.

Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells.

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

P304

115-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19382014.2016.1199303

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27328412

http://www.w3.org/2001/XMLSchema#string

P932

5029202

http://www.w3.org/2001/XMLSchema#string